New human data hints at psychedelics' potential to combat inflammation
Source:
nprNews
October 21, 2026 · 08:33
From the publisher
Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease.
The original article opens on the publisher's website.
More from General
View topic →What is PHP and why did it spark a global cyber security scramble?
bbcTechnology
Oct 21, 2026 · 20:48
China's stock market sinks into bear territory as CSI 300 extends 10-week rout
cnbc
Oct 21, 2026 · 20:35
Hackers Exploited the PHP Vulnerabilities Days Before They Were Patched
wired
Oct 21, 2026 · 19:24
Southeast Asia is hungry for AI — and the money isn't just in subscriptions
cnbc
Oct 21, 2026 · 18:22
James Talarico fires back at Elon Musk in Texas Senate race feud
cnbc
Oct 21, 2026 · 18:21